Eastern Bank cut its stake in shares of Cabot Corporation (NYSE:CBT – Free Report) by 8.9% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 202,300 shares of the specialty chemicals company’s stock after selling 19,759 shares during the quarter. Eastern Bank’s holdings in Cabot were worth $18,373,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Torren Management LLC acquired a new stake in shares of Cabot during the fourth quarter worth $26,000. Rothschild Investment LLC boosted its position in shares of Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 259 shares during the period. Global Retirement Partners LLC increased its stake in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in Cabot during the 3rd quarter worth about $38,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have commented on CBT shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. JPMorgan Chase & Co. boosted their price target on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a report on Wednesday, May 13th. Wall Street Zen downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Saturday. UBS Group raised their price objective on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. Finally, Truist Financial started coverage on shares of Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 price objective on the stock. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $85.80.
Cabot Stock Up 2.2%
Shares of Cabot stock opened at $90.00 on Tuesday. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53. The company has a market cap of $4.65 billion, a P/E ratio of 17.01, a P/E/G ratio of 11.46 and a beta of 0.84. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The stock has a 50-day moving average price of $88.03 and a 200 day moving average price of $79.56.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts expect that Cabot Corporation will post 6.35 EPS for the current fiscal year.
Cabot Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.1%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is currently 35.73%.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Articles
- Five stocks we like better than Cabot
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
